Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Gomes, July Silveira
Shiozawa, Pedro
Dias, Álvaro Machado
Valverde Ducos, Daniella
Akiba, Henrique
Trevizol, Alisson Paulino
Bikson, Marom
Aboseria, Mohamed
Gadelha, Ary
de Lacerda, Aciolly Luiz Tavares
and
Cordeiro, Quirino
2015.
Left Dorsolateral Prefrontal Cortex Anodal tDCS Effects on Negative Symptoms in Schizophrenia.
Brain Stimulation,
Vol. 8,
Issue. 5,
p.
989.
Arts, Klaas
2015.
Secundaire psychosen bij behandelbare neurologische aandoeningen.
Tijdschrift voor Neuropsychiatrie en Gedragsneurologie,
Vol. 3,
Issue. 1,
p.
17.
Schlosser, Danielle A.
Campellone, Timothy R.
Biagianti, Bruno
Delucchi, Kevin L.
Gard, David E.
Fulford, Daniel
Stuart, Barbara K.
Fisher, Melissa
Loewy, Rachel L.
and
Vinogradov, Sophia
2015.
Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
Schizophrenia Research,
Vol. 169,
Issue. 1-3,
p.
204.
Hasan, Alkomiet
Strube, Wolfgang
Palm, Ulrich
and
Wobrock, Thomas
2016.
Repetitive Noninvasive Brain Stimulation to Modulate Cognitive Functions in Schizophrenia: A Systematic Review of Primary and Secondary Outcomes.
Schizophrenia Bulletin,
Vol. 42,
Issue. suppl 1,
p.
S95.
Kang, Ruiying
Wu, Yeqing
Li, Zhiwu
Jiang, Jun
Gao, Qi
Yu, Yuncui
Gao, Keming
Yan, Yuxiang
and
He, Yan
2016.
Effect of Community-Based Social Skills Training and Tai-Chi Exercise on Outcomes in Patients with Chronic Schizophrenia: A Randomized, One-Year Study.
Psychopathology,
Vol. 49,
Issue. 5,
p.
345.
Hasan, Alkomiet
Guse, Birgit
Cordes, Joachim
Wölwer, Wolfgang
Winterer, Georg
Gaebel, Wolfgang
Langguth, Berthold
Landgrebe, Michael
Eichhammer, Peter
Frank, Elmar
Hajak, Göran
Ohmann, Christian
Verde, Pablo E.
Rietschel, Marcella
Ahmed, Raees
Honer, William G.
Malchow, Berend
Karch, Susanne
Schneider-Axmann, Thomas
Falkai, Peter
and
Wobrock, Thomas
2016.
Cognitive Effects of High-Frequency rTMS in Schizophrenia Patients With Predominant Negative Symptoms: Results From a Multicenter Randomized Sham-Controlled Trial.
Schizophrenia Bulletin,
Vol. 42,
Issue. 3,
p.
608.
Chi, SuHyuk
Jeong, Hyun-Ghang
Lee, Moon-soo
and
Kim, Seung-Hyun
2016.
Factors Predicting Personal and Social Performance in Schizophrenia Patients.
Korean Journal of Schizophrenia Research,
Vol. 19,
Issue. 2,
p.
47.
Davis, Robert E.
and
Correll, Christoph U.
2016.
ITI-007 in the treatment of schizophrenia: from novel pharmacology to clinical outcomes.
Expert Review of Neurotherapeutics,
Vol. 16,
Issue. 6,
p.
601.
Shrivastava, Amresh
De Sousa, Avinash
and
Sule, Rucha
2016.
Wellness as a Means for Better Quality of Life in Schizophrenia.
Journal of Psychosocial Rehabilitation and Mental Health,
Vol. 3,
Issue. 2,
p.
109.
Preissmann, D.
Dépré, M.
Schenk, F.
and
Gisquet-Verrier, P.
2016.
Anxiety modulates cognitive deficits in a perinatal glutathione deficit animal model of schizophrenia.
Brain Research,
Vol. 1648,
Issue. ,
p.
459.
Schreiner, Andreas
Bergmans, Paul
Cherubin, Pierre
and
Hargarter, Ludger
2017.
The effect of long-acting paliperidone palmitate once-monthly on negative and depressive symptoms in patients with schizophrenia switched from previous unsuccessful treatment with oral aripiprazole.
Therapeutic Advances in Psychopharmacology,
Vol. 7,
Issue. 2,
p.
59.
Hasan, Alkomiet
Falkai, Peter
Wobrock, Thomas
Lieberman, Jeffrey
Glenthøj, Birte
Gattaz, Wagner F.
Thibaut, Florence
and
Möller, Hans-Jürgen
2017.
World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia – a short version for primary care.
International Journal of Psychiatry in Clinical Practice,
Vol. 21,
Issue. 2,
p.
82.
Hurtubise, Jessica L.
Marks, Wendie N.
Davies, Don A.
Catton, Jillian K.
Baker, Glen B.
and
Howland, John G.
2017.
MK-801-induced impairments on the trial-unique, delayed nonmatching-to-location task in rats: effects of acute sodium nitroprusside.
Psychopharmacology,
Vol. 234,
Issue. 2,
p.
211.
Steen, Nils Eiel
Aas, Monica
Simonsen, Carmen
Dieset, Ingrid
Tesli, Martin
Nerhus, Mari
Gardsjord, Erlend
Mørch, Ragni
Agartz, Ingrid
Melle, Ingrid
Ueland, Torill
Spigset, Olav
and
Andreassen, Ole A.
2017.
Serum levels of second-generation antipsychotics are associated with cognitive function in psychotic disorders.
The World Journal of Biological Psychiatry,
Vol. 18,
Issue. 6,
p.
471.
Biagiarelli, Mario
Curto, Martina
Di Pomponio, Ileana
Comparelli, Anna
Baldessarini, Ross J.
and
Ferracuti, Stefano
2017.
Antipsychotic treatment and the Rorschach Perceptual Thinking Index (PTI) in psychotic disorder patients: Effects of treatment.
Psychiatry Research,
Vol. 251,
Issue. ,
p.
294.
Bernstein, Hans-Gert
Müller, Susan
Dobrowolny, Hendrik
Wolke, Carmen
Lendeckel, Uwe
Bukowska, Alicja
Keilhoff, Gerburg
Becker, Axel
Trübner, Kurt
Steiner, Johann
and
Bogerts, Bernhard
2017.
Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia.
European Archives of Psychiatry and Clinical Neuroscience,
Vol. 267,
Issue. 5,
p.
427.
Solmi, Marco
Veronese, Nicola
Thapa, Nita
Facchini, Silvia
Stubbs, Brendon
Fornaro, Michele
Carvalho, André F.
and
Correll, Christoph U.
2017.
Systematic review and meta-analysis of the efficacy and safety of minocycline in schizophrenia.
CNS Spectrums,
Vol. 22,
Issue. 5,
p.
415.
Zhang, Xiao
Zhang, Yuyanan
Liao, Jinmin
Jiang, Sisi
Yan, Jun
Yue, Weihua
Zhang, Dai
and
Yan, Hao
2018.
Progressive Grey Matter Volume Changes in Patients with Schizophrenia over 6 Weeks of Antipsychotic Treatment and Their Relationship to Clinical Improvement.
Neuroscience Bulletin,
Vol. 34,
Issue. 5,
p.
816.
van den Noort, Maurits
Yeo, Sujung
Lim, Sabina
Lee, Sook-Hyun
Staudte, Heike
and
Bosch, Peggy
2018.
Acupuncture as Add-On Treatment of the Positive, Negative, and Cognitive Symptoms of Patients with Schizophrenia: A Systematic Review.
Medicines,
Vol. 5,
Issue. 2,
p.
29.
van den Noort, Maurits
and
Bosch, Peggy
2018.
Schizophrenia and Sleep Disorders: An Introduction.
Medicines,
Vol. 5,
Issue. 3,
p.
94.